Publications by authors named "Maria Amato"

Claim this Profile
E
Early response in cytokine and miR-124a, -125b, -223 expression to anti-CD20 in Multiple Sclerosis and its animal model - a preliminary analysis.
Nicola Salvatore Orefice, Roberta Amoriello, Olfa Maghrebi, Chiara Ballerini, Giovanni Baldi, Maria Pia Amato

J Neuroimmunol· February 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Managing reactivation of multiple sclerosis during treatment with natalizumab.
Nathaniel Lizak, Sifat Sharmin, Dana Horáková, Eva Kubala Havrdova, Sara Eichau, Maria Pia Amato

Mult Scler· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Consensus on recommended evaluation tools in multiple sclerosis (CORE-MS): A Delphi study protocol on balance and gait assessment.
Rebecca Cardini, Elisa Gervasoni, Marco Germanotta, Irene Giovanna Aprile, Francesca Cecchi, Maria Pia Amato

PLoS One· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Disability Worsening Phenotypes in Multiple Sclerosis and Impact of Disease-Modifying Treatments.
Ermelinda De Meo, Ilaria Addazio, Emilio Portaccio, Raffaello Bonacchi, Matteo Betti, Maria Pia Amato

Neurology· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Machine Learning Analysis Applied to Prediction of Early Progression Independent of Relapse Activity in Multiple Sclerosis Patients.
Valentina Poretto, Walter Endrizzi, Matteo Betti, Stefano Bovo, Angelo Bellinvia, Maria Pia Amato

Eur J Neurol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Not Available].
Luca Pianigiani, Crescenza Mazzaraco, Giulia Centini, Valentina Bruchi, Gabriele Cercaci, Maria Giovanna D'Amato

Recenti Prog Med· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Building on European Reference Network for Rare Neurological Diseases (ERN-RND) Experience: Integrating Motor and Non-Motor Assessment in Pediatric Movement Disorders.
Maria Eugenia Amato, Juan Darío Ortigoza-Escobar

Mov Disord· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effectiveness of Rituximab in rElapsiNg Multiple SclErosis previously treated with hiGhly-Active Disease modifying thErapies (RENEGADE study).
Clara Grazia Chisari, Salvatore Lo Fermo, Alessia Di Sapio, Maria Pia Amato, Giuseppe Salemi

J Neurol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Benralizumab Affects Specific Compartments in Severe Asthma Patients With Chronic Rhinosinusitis and Nasal Polyposis.
Debora Paris, Claudio Candia, Antonio Molino, Maria D'Amato, Andrea Motta

Clin Exp Allergy· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparative Effectiveness of Cladribine and S1P Receptor Modulators in Treatment-Naive Relapsing-Remitting MS.
Shalom Haggiag, Luca Prosperini, Massimo Filippi, Maria A Rocca, Pietro Iaffaldano, Maria Pia Amato

JAMA Netw Open· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The brief repeatable battery of neuropsychological test (BRB-N) version B: update of Italian normative data.
Nicolò Tedone, Marta Grosselle, Emilio Portaccio, Maria Pia Amato, Damiano Mistri

J Neurol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adherence and compliance with exercise training in progressive multiple sclerosis: Rates and correlates from the CogEx trial.
Robert W Motl, Andrew Argie, Roberto S Hernandez, Brian M Sandroff, Maria Pia Amato

Mult Scler Relat Disord· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early Intensive Versus Escalation Approach: Ten-Year Impact on Disability in Relapsing Multiple Sclerosis.
Pietro Iaffaldano, Giuseppe Lucisano, Tommaso Guerra, Francesca Caputo, Marta Simone, Maria Pia Amato

Ann Clin Transl Neurol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A narrative review of genetic and environmental factors and risk for multiple sclerosis. The design of the Italian multicentric PEDIGREE study.
Angelo Ghezzi, Sandra D'Alfonso, Maura Pugliatti, Silvy Pilotto, Martina Tosi, Maria Pia Amato

Neurol Sci· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Moving Closer to the Prevention of Cognitive Disability in People With Pediatric-Onset Multiple Sclerosis.
Emilio Portaccio, Maria Pia Amato

Neurology· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Toward a Unified Definition of Progression Independent of Relapse Activity in Multiple Sclerosis.
Emilio Portaccio, Matteo Betti, Ermelinda De Meo, Luisa Pastò, Elio Prestipino, Maria Pia Amato

Neurology· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinically Relevant Patterns of Co-Fluctuating Structure and Function in Multiple Sclerosis.
Jian Zhang, Marco Battaglini, Rosa Cortese, Maria Laura Stromillo, Marzia Mortilla, Maria Pia Amato

Eur J Neurol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Optimising care for chronic rhinosinusitis with nasal polyps and asthma in multimorbid patients: a multidisciplinary Delphi consensus.
Eugenio De Corso, Adriano Vaghi, Marco Corbò, Carlotta Pipolo, Alessandra Vultaggio, Maria D'Amato

Acta Otorhinolaryngol Ital· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Deep Learning Modeling to Differentiate Multiple Sclerosis From MOG Antibody-Associated Disease.
Rosa Cortese, Francesco Sforazzini, Giordano Gentile, Anna de Mauro, Ludovico Luchetti, Maria Pia Amato

Neurology· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Persistent progression independent of relapse activity in multiple sclerosis.
Chao Zhu, Zhen Zhou, Tomas Kalincik, Izanne Roos, Katherine Buzzard, Maria Pia Amato

Brain Commun· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of the Arg16Gly β-Adrenergic Receptor Polymorphism on Long-Term Mepolizumab Response and Clinical Remission in Severe Eosinophilic Asthma: A Genotype-Stratified, Multicenter Study.
Santi Nolasco, Evelina Fagone, Raffaele Campisi, Andrea Portacci, Giulia Scioscia, Maria D'Amato

Allergy· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of cognitive rehabilitation and exercise on brain structure in progressive multiple sclerosis: results from the CogEx trial.
Francesco Romanò, Maria A Rocca, Elisabetta Pagani, Maria Pia Amato, Giampaolo Brichetto

J Neurol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The use of high-efficacy disease-modifying therapies in multiple sclerosis: recommendations from an expert Delphi consensus.
Massimo Filippi, Maria Pia Amato, Diego Centonze, Paolo Gallo, Claudio Gasperini

J Neurol· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Biologic Therapy in Severe Asthma: A Phenotype-Driven and Targeted Approach.
Maria D'Amato, Daniela Pastore, Chiara Lupia, Claudio Candia, Andrea Bruni

J Clin Med· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Personalized federated learning for predicting disability progression in multiple sclerosis using real-world routine clinical data.
Ashkan Pirmani, Edward De Brouwer, Ádám Arany, Martijn Oldenhof, Antoine Passemiers, Maria Pia Amato

NPJ Digit Med· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis